75 related articles for article (PubMed ID: 9288787)
41. Transcript map and comparative analysis of the 1.5-Mb commonly deleted segment of human 5q31 in malignant myeloid diseases with a del(5q).
Lai F; Godley LA; Joslin J; Fernald AA; Liu J; Espinosa R; Zhao N; Pamintuan L; Till BG; Larson RA; Qian Z; Le Beau MM
Genomics; 2001 Jan; 71(2):235-45. PubMed ID: 11161817
[TBL] [Abstract][Full Text] [Related]
42. EHT, a new member of the MTG8/ETO gene family, maps on 20q11 region and is deleted in acute myeloid leukemias.
Fracchiolla NS; Colombo G; Finelli P; Maiolo AT; Neri A
Blood; 1998 Nov; 92(9):3481-4. PubMed ID: 9787195
[No Abstract] [Full Text] [Related]
43. Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22.
Curtiss NP; Bonifas JM; Lauchle JO; Balkman JD; Kratz CP; Emerling BM; Green ED; Le Beau MM; Shannon KM
Genomics; 2005 May; 85(5):600-7. PubMed ID: 15820312
[TBL] [Abstract][Full Text] [Related]
44. Lack of rearrangements of p53 tumor antigen gene locus in human hematological malignancies.
Venturelli D; Ku DH; Narni F; Gatti C; Calabretta B
Haematologica; 1988; 73(4):259-64. PubMed ID: 3139527
[No Abstract] [Full Text] [Related]
45. [Molecular organization of the complete gene encoding a human cellular tumor antigen (p53)].
Bukhman VL; Ninkina NN; Samarina OP; Matveeva OV; Chumakov PM
Dokl Akad Nauk SSSR; 1987; 292(1):223-6. PubMed ID: 3028744
[No Abstract] [Full Text] [Related]
46. Functionally inactivating point mutation in the tumor-suppressor IRF-1 gene identified in human gastric cancer.
Nozawa H; Oda E; Ueda S; Tamura G; Maesawa C; Muto T; Taniguchi T; Tanaka N
Int J Cancer; 1998 Aug; 77(4):522-7. PubMed ID: 9679752
[TBL] [Abstract][Full Text] [Related]
47. Human mortalin (HSPA9): a candidate for the myeloid leukemia tumor suppressor gene on 5q31.
Xie H; Hu Z; Chyna B; Horrigan SK; Westbrook CA
Leukemia; 2000 Dec; 14(12):2128-34. PubMed ID: 11187902
[TBL] [Abstract][Full Text] [Related]
48. Polymorphism in and localization of the gene LCP2 (SLP-76) to chromosome 5q33.1-qter.
Sunden SL; Carr LL; Clements JL; Motto DG; Koretzky GA
Genomics; 1996 Jul; 35(1):269-70. PubMed ID: 8661136
[No Abstract] [Full Text] [Related]
49. A novel, evolutionarily conserved gene family with putative sequence-specific single-stranded DNA-binding activity.
Castro P; Liang H; Liang JC; Nagarajan L
Genomics; 2002 Jul; 80(1):78-85. PubMed ID: 12079286
[TBL] [Abstract][Full Text] [Related]
50. Human selenoprotein P gene maps to 5q31.
Hill KE; Dasouki M; Phillips JA; Burk RF
Genomics; 1996 Sep; 36(3):550-1. PubMed ID: 8884283
[No Abstract] [Full Text] [Related]
51. High resolution physical mapping of human HDAC3, a potential tumor suppressor gene in the 5q31 region.
Mahlknecht U; Bucala R; Hoelzer D; Verdin E
Cytogenet Cell Genet; 1999; 86(3-4):237-9. PubMed ID: 10575214
[TBL] [Abstract][Full Text] [Related]
52. Analysis of the Smad5 gene in hematological malignancies.
Ikezoe T; Takeuchi S; Kobayashi M; Taguchi H
Am J Hematol; 1999 Mar; 60(3):249. PubMed ID: 10072124
[No Abstract] [Full Text] [Related]
53. HRap1B-retro: a novel human processed rap1B gene blurs the picture?
Zemojtel T; Penzkofer T; Duchniewicz M; Zwartkruis FJ
Leukemia; 2006 Jan; 20(1):145-6; author reply 146-7. PubMed ID: 16307016
[No Abstract] [Full Text] [Related]
54. Absence of loss of heterozygosity of the IRF1 gene in some patients with a 5q31 deletion.
Kroef MJ; Bolk MW; Willemze R; Landegent JE
Blood; 1994 Apr; 83(8):2382. PubMed ID: 8161805
[No Abstract] [Full Text] [Related]
55. A candidate new gene on human chromosome 5q12 contains a motif that is found in transcriptional co-activators.
Angelopoulou K; Prody C; Diamandis EP
Clin Biochem; 1998 Nov; 31(8):687-8. PubMed ID: 9876903
[No Abstract] [Full Text] [Related]
56. Structural basis for the Smad5 MH1 domain to recognize different DNA sequences.
Chai N; Li WX; Wang J; Wang ZX; Yang SM; Wu JW
Nucleic Acids Res; 2017 Jun; 45(10):6255-6257. PubMed ID: 28369590
[No Abstract] [Full Text] [Related]
57. Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies.
Ye Y; McDevitt MA; Guo M; Zhang W; Galm O; Gore SD; Karp JE; Maciejewski JP; Kowalski J; Tsai HL; Gondek LP; Tsai HC; Wang X; Hooker C; Smith BD; Carraway HE; Herman JG
Cancer Res; 2009 Nov; 69(21):8482-90. PubMed ID: 19826047
[TBL] [Abstract][Full Text] [Related]
58. Tid1 is a Smad-binding protein that can modulate Smad7 activity in developing embryos.
Torregroza I; Evans T
Biochem J; 2006 Jan; 393(Pt 1):311-20. PubMed ID: 16156721
[TBL] [Abstract][Full Text] [Related]
59. SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.
Zimonjic DB; Durkin ME; Keck-Waggoner CL; Park SW; Thorgeirsson SS; Popescu NC
Neoplasia; 2003; 5(5):390-6. PubMed ID: 14670176
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
